Showing results (451-460 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|November 14, 2024
Residue-resolved insights into the stabilization of therapeutic proteins by excipients: A case study of two monoclonal antibodies with arginine and glutamateTobias M Prass, Patrick Garidel, Lars V Schäfer, et al.Mabs|February 14, 2025
Combinatorial Fc modifications for complementary antibody functionalityYannic C Bartsch, Nicholas E Webb, Eleanor Burgess, et al.Mabs|November 5, 2024
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studiesYizhou Zhang, Ruicheng Wei, Ge Song, et al.Mabs|October 15, 2025
Computational analysis reveals non-consensus N-glycosylation sequons in antibody Fab regionBaiyu Qiu, Edwin Chen, Tawnya Flick, et al.Mabs|October 14, 2025
Development, qualification, and application of a highly efficient and robust new peak detection workflow for the LC-MS peptide mapping multi-attribute methodThomas Pohl, Patrick Sascha Merkle, Sonja Hudelmaier, et al.Mabs|September 26, 2025
Accelerating antibody development: sequence and structure-based models for predicting developability properties via size exclusion chromatographyA N M Nafiz Abeer, Mehdi Boroumand, Isabelle Sermadiras, et al.Mabs|September 22, 2025
A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriersPhilipp Kuhn, Sabrina Petralla, Fatemeh Dabbagh, et al.Mabs|September 25, 2025
Development of a PRAME pMHC targeted T cell engager for solid tumor therapyKatarzyna Skrzypczynska, Kristin Schimert, Heather Stephenson, et al.Mabs|December 31, 2020
Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibodyDavid Falck, Marco Thomann, Martin Lechmann, et al.Pageof 180